
NDB
CAS No. 1660153-08-1
NDB ( —— )
产品货号. M35688 CAS No. 1660153-08-1
NDB 是一种选择性人 FXRα (hFXRα) 拮抗剂,可有效调节 FXRα 下游基因的转录。NDB可用于抗糖尿病研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1279 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称NDB
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NDB 是一种选择性人 FXRα (hFXRα) 拮抗剂,可有效调节 FXRα 下游基因的转录。NDB可用于抗糖尿病研究。
-
产品描述NDB is a selective human FXRα (hFXRα) antagonist that is effective in modulating transcription of FXRα downstream genes. NDB can be used in anti-diabetes research.
-
体外实验NDB induces rearrangements of helix 11 (H11) and helix 12 (H12, AF-2) by forming a homodimer of hFXRα-LBD, totally different from the active conformation in monomer state.NDB (25 μM) effectively antagonizes the GW4064-stimulated FXR/RXR interaction and FXRα target gene expression in primary mouse hepatocytes, including the small heterodimer partner (SHP) and bile-salt export pump (BSEP).
-
体内实验Cofrogliptin (HSK7653) (compound 2) (IV: 0.5 mg/kg; PO: 2 mg/kg) exhibits extremely long half-lives and low rate of reduction of drug concentration after orally administration.Cofrogliptin (compound 2) (Single, orally, 3 mg/kg, 10 mg/kg, 30 mg/kg) increases of half-lives, has high oral exposure, low i.v. clearance and hepatic microsomal clearance after intravenous dosing. Cofrogliptin (compound 2) (Single, orally, 10 mg/kg) exhibits longe inhibition time of DPP-4 and decreases HbA1c level at the doses of 3 and 10 mg/kg in ob/ob mice. Cofrogliptin (compound 2) (Single, orally, 10 mg/kg) also has a great potential of biweekly regimen for T2DM as indicated in rhesus monkeys.Animal Model:ob/ob mice Dosage:3 mg/kg, 10 mg/kg, 30 mg/kg Administration: Single, orally, 3 mg/kg, 10 mg/kg, 30 mg/kg Result:Exhibited strong inhibition capability of plasma DPP-4 in a dose dependent manner. Animal Model:rhesus monkeys Dosage:10 mg/kg Administration:Single, orally, 10 mg/kg Result: Possessed the capability of plasma DPP-4 inhibition over 80% for at least 12 days.Remained the plasma DPP-4 inhibition rates of 76.16% and 43.41%, respectively at the end of second week and third week after administration.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点FXR
-
受体FXR
-
研究领域——
-
适应症——
化学信息
-
CAS Number1660153-08-1
-
分子量471.42
-
分子式C26H28Cl2N2O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (212.13 mM; 超声助溶 )
-
SMILESCN(C)c1cc(Cl)c(C(=O)N(Cc2ccccc2)c2ccc(O)c(c2)C(C)(C)C)c(Cl)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Xing Xu, et al. Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor. ?
产品手册




关联产品
-
Altenusin
Altenusin 是一种天然非甾体真菌代谢物,作为 FXR 的新型选择性激动剂,EC50 值为 3.2 ± 0.2 μM。
-
Tauro-Obeticholic ac...
牛磺奥贝胆酸是一种活性奥贝胆酸代谢物。 Obeticholic Acid 是一种口服生物可利用的法尼醇 X 受体 (FXR) 激动剂。
-
Tropifexor
Tropifexor (LJN-452, LJN452) 是一种新型高效、选择性、口服活性 FXR 完全激动剂,EC50 为 0.26 nM。